Covid vaccine boosters approved for vulnerable groups in Switzerland
People with a high risk of developing serious complications from Covid-19 may now receive a third vaccine booster jab, the Swiss medicines regulator has stated.
This content was published on
3 minutes
swissinfo.ch/mga
Español
es
Suiza avala la dosis de refuerzo de la vacuna contra la COVID-19
Swissmedic cleared the use of boosters from vaccine makers Moderna (Spikevax) and Pfizer/Biontech (Comirnaty).
“People at especially high risk can receive a booster dose of a vaccine in order to remain adequately protected against severe episodes of Covid-19,” Swissmedic stated on TuesdayExternal link.
This includes immunocompromised people or patients with a weak or non-existent immune response from previous jabs. This could include people who have undergone an organ transplant or cancer patients.
“The latest study data indicate that an additional dose can increase the ability to form antibodies against the coronavirus SARS-CoV-2, particularly in patients with a weakened immune system,” said Swissmedic. “Those who are at especially high risk can also benefit from a booster dose.”
The Federal Office of Public Health said the booster jab should be limited to vulnerable sections of the population, including people aged over 65.
“For the general population, a booster vaccination is currently not permitted and not recommended due to the current data situation,” health officials stated on TuesdayExternal link.
People can start applying for a third booster jab from the beginning of next month when IT systems will be ready to deal with the expected flow of requests.
Dose schedule
A third dose for vulnerable people can now be administered at least six months after they received their second dose. For patients who showed little or no immune response reaction to their first two jabs, a booster can be administered after 28 days of the second jab.
The booster jab will be administered at the usual dosage for the Comirnaty vaccine and a half dose for the Spikevax vaccine.
Switzerland received some 7,700 extra vaccine doses at the end of last week. The government has ordered seven million new doses from Moderna and Pfizer/BioNtech to be delivered next year.
The number of new infections has been rising in Switzerland in recent weeks. Some 1,491 cases were reported on Tuesday, mainly among younger people. The seven-day average stands at 1,237 – an increase of 35% from the previous period.
However, the number of hospitalisations remains stable and there has been a slight decrease in the number of deaths.
During a press conference on Tuesday, Tanja Stadler, head of Switzerland’s Covid-19 science taskforce, said that two vaccine jabs can prevent eight out of ten hospitalisations.
More
More
Coronavirus: the situation in Switzerland
This content was published on
An overview of the latest Covid-related information in the Alpine nation.
Should Switzerland take measures to support its struggling industries?
Industrial policies are back in fashion, not only in the United States but also in the EU. Should Switzerland, where various industries are struggling, draw inspiration from such policies?
As a Swiss Abroad, how do you feel about the emergence of more conservative family policies in some US states?
In recent years several US states have adopted more conservative policies on family issues, abortion and education. As a Swiss citizen living there, how do you view this development?
This content was published on
A committee of Switzerland’s House of Representatives has found the people’s initiative to limit fireworks too extreme, but has suggested a counter-proposal.
UN investigators report evidence of crimes in Syria and call for national dialogue
This content was published on
UN investigators in Geneva report ample evidence of crimes in Syria and urge the regime to follow through on its promise of a national dialogue.
Swiss Trade Union warns EU deal could threaten wages
This content was published on
The Swiss Trade Union Federation warns that the new bilateral agreement between Switzerland and the EU could threaten wage protection and public services.
Credit Suisse fines from Mozambique scandal to fund victims’ compensation
This content was published on
The fines imposed on Credit Suisse for the Mozambique scandal will be allocated to a fund for the victims, amounting to $105.5 million.
‘Confederation is a subsidy machine’: Swiss finance minister
This content was published on
The Swiss government is a machine for distributing subsidies to various actors in the country, says finance minister Karin Keller-Sutter.
Lack of funds ends third bid to salvage Säntis ship from Swiss lake
This content was published on
A third attempt to salvage the steamship Säntis, lying at the bottom of Lake Constance in Switzerland since 1933, has failed before it has even begun.
Nestlé Waters on trial in France over illegal waste dumps
This content was published on
Bottled water producer Nestlé Waters to stand trial, accused of illegally dumping waste and maintaining unauthorised dumps.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Switzerland awaits regulator’s verdict on Covid booster shots
This content was published on
On Thursday, Swiss Health Minister Alain Berset said the government and cantons are awaiting Swissmedic’s recommendation of a third dose of the vaccine before proceeding. “We have regular exchanges with the Federal Vaccination Commission and the cantons. We are waiting for the decision of Swissmedic,” Berset said. That could be a matter of days or weeks, according…
Over 1% of recent Swiss Covid-19 fatalities were fully vaccinated
This content was published on
Of the 1,100 people killed by the coronavirus in Switzerland since the end of January, 18 had received both doses of the vaccine.
Swiss expect approval of Covid-19 booster by end of October
This content was published on
Switzerland’s medical regulator has said that it expects to give the greenlight for the third Covid-19 jab in a matter of weeks.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.